Asset

CSL LIMITED

CSL
equity
AUD $300.11
stockPerformance -2.47 (-0.82%)
Updated: 30 Nov, 5:10 am UTC
04 Jan01 Mar29 Apr24 June18 Aug14 Oct30 Nov240245250255260265270275280285290295300305
Description
CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.